CASE COMMENTS : ANTICOMPETITIVE AGREEMENT - PAY FOR DELAY – GENERIC – FINES

Pay for delay: The European Commission fines Lundbeck and other pharmaceutical companies for delaying market entry of generic medicines (Lundbeck)

KEYWORDS
Reference

Eur. Com., press releases IP/13/563, 19.06.2013, Antitrust: Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The Commission has fined the Danish

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.